Drug delivery device with electronics

    公开(公告)号:US11554226B2

    公开(公告)日:2023-01-17

    申请号:US16875282

    申请日:2020-05-15

    IPC分类号: A61M15/00 G16H40/40 G16H20/13

    摘要: A system may include an external device and an inhaler. The external device may include a processor, a communication circuit, and memory. The inhaler may include a mouthpiece, medicament, a mechanical dose counter, and an electronics module comprising a processor and a communication circuit. The electronics module may record a dosing event when the inhaler is actuated, such as when the mouthpiece cover is opened, and send a signal indicating the dosing event to the external device. The external device may receive a mechanical dose reading of the mechanical dose counter, determine an electronic dose reading based on the signal indicating the dosing event, determine that a discrepancy between the mechanical dose reading and the electronic dose reading exceeds a threshold, and notify the user of the discrepancy, for example, by providing a notification to the user by way of a mobile application residing on the external device.

    INHALER SYSTEM
    32.
    发明申请

    公开(公告)号:US20220401667A1

    公开(公告)日:2022-12-22

    申请号:US17896526

    申请日:2022-08-26

    摘要: Provided is a system comprising a plurality of inhalers that each include a processor configured to determine a value of a usage parameter relating to use of the respective first inhaler, encrypt data based on the value, and transmit the encrypted data. At least two of the inhalers include different medicament, such as a rescue medicament and a maintenance medicament. The system includes an external device that includes a processor configured to distinguish between the encrypted data of each respective inhaler, determine respective usage information relating to each of the distinct types of medicament based on the respective encrypted data, and control a user interface (e.g., of the external device) to communicate the usage information related to each inhaler and/or each respective type of medicament.

    Inhaler system
    33.
    发明授权

    公开(公告)号:US11464923B2

    公开(公告)日:2022-10-11

    申请号:US16906896

    申请日:2020-06-19

    摘要: Provided is a system including a plurality of inhalers that each include a processor configured to determine a value of a usage parameter relating to use of the respective first inhaler, encrypt data based on the value, and transmit the encrypted data. At least two of the inhalers include different medicament, such as a rescue medicament and a maintenance medicament. The system includes an external device that includes a processor configured to distinguish between the encrypted data of each respective inhaler, determine respective usage information relating to each of the distinct types of medicament based on the respective encrypted data, and control a user interface (e.g., of the external device) to communicate the usage information related to each inhaler and/or each respective type of medicament.

    Inhaler System
    34.
    发明申请

    公开(公告)号:US20220148730A1

    公开(公告)日:2022-05-12

    申请号:US17505821

    申请日:2021-10-20

    IPC分类号: G16H50/20 G16H50/30 G16H20/13

    摘要: A system may include a plurality of inhalers, where each inhaler comprising medicament, a processor, memory, and a transmitter, multiple processing modules that may reside at least partially on a user device, a digital health platform (DHP) that is configured to receive and aggregate inhaler data from inhalers that are associated with a plurality of different users and a plurality of different medicament types. The DHP may be configured to train a machine learning algorithm using training data via a supervised or an unsupervised learning method, wherein the training data comprises the time and the one or more inhalation parameters associated with each of the plurality of usage events. The DHP also configured to generate a compliance score, a future compliance score, and/or a risk score using the trained machine learning algorithm, and cause a display device to generate a notification indicating the score for the user.

    INHALER SYSTEM
    35.
    发明申请

    公开(公告)号:US20210393892A1

    公开(公告)日:2021-12-23

    申请号:US16906651

    申请日:2020-06-19

    IPC分类号: A61M15/00

    摘要: Provided is a system comprising an inhaler. The inhaler comprises a use determination system. The use determination system is configured to determine a parameter relating to airflow during a use of the inhaler by a subject. The use determination system also assigns a time to the use. The system also comprises a user interface, and a processing module. The processing module is configured to determine inhalation information from the parameter, and control the user interface to issue a notification that the inhalation information is available. The notification is issued at a notification time. The processing module is configured to implement a deliberate time delay such that the notification time is delayed relative to the time assigned to the use.

    Inhaler
    36.
    发明授权
    Inhaler 有权

    公开(公告)号:US11000653B2

    公开(公告)日:2021-05-11

    申请号:US15704444

    申请日:2017-09-14

    IPC分类号: A61M15/00 A61B5/00

    摘要: The introduction of electronics into a drug delivery device may introduce certain technical challenges, such as durability, electro-mechanical integration, and drug delivery performance. The present disclosure provides solutions for inclusion of an electronics module with an inhaler. For example, heat stakes may be used to secure a printed circuit board (PCB) to an electronics module's housing. Also for example, a slider may be used to transfer vertical movement of an inhaler's yoke to an electronics module's switch. Also for example, certain seals may be used when interfacing the electronics module to other portions of the device's housing to achieve a desired performance.

    Breath actuated inhaler
    37.
    发明授权

    公开(公告)号:US10792447B2

    公开(公告)日:2020-10-06

    申请号:US16258330

    申请日:2019-01-25

    摘要: A breath actuated metered dose inhaler may include a canister fire system configured to fire a medicament containing canister in response to patient inhalation. The canister fire system may include a pneumatic force holding unit and having a rest configuration in which a metering valve of the canister is in a refill configuration; a prepared configuration in which a canister actuation force is retained by the pneumatic force holding unit and the canister fire system is actuatable by patient inhalation induced airflow; and a fire configuration in which the metering valve is in a dose delivery position. When in the prepared configuration, the force retained by the so pneumatic force holding unit may be reduced by less than about 6% over a period of 5 minutes, preferably less than about 3% over a period of 5 minutes.